IP Blueprint for Growth
How innovative SMEs can attract and secure funding
Potter Clarkson introduces IP tools to fuel business growth
Built around the specific challenges faced by start-ups, SMEs and investors, these fixed-price IP tools are designed to maximise the commercial value from innovative ideas at each milestone.
With the transition period now over, it is important to consider how you will secure and maintain protection - both in the EU and the UK.
Covid-19: update on procedures
Like all organisations, intellectual property offices have had to make changes to the way they operate at the current time to limit the spread of Covid-19.
Potter Clarkson creates value from your innovation. We bring vision and clarity of thought to guide you through the complexities of intellectual property for business. As consultants and experts in IP law, we help you understand, create, protect and defend the commercial value of your innovations anywhere in the world.
LITIGATION AND LICENSING
OUR LATEST INSIGHTS
Hollow Crown? Vodafone’s “crown use” defence overturned by Court of Appeal
Artificial intelligence and inventorship: News round-up
- Event name
View Brand evolution: Creating and developing a successful brand
- Brand evolution: Creating and developing a successful brand
View Innovation capture: What to look for and how to capture it effectively
- Innovation capture: What to look for and how to capture it effectively
View Software patents: Case studies
- Software patents: Case studies
THE DIFFERENCE WE MAKE
Helping our clients to achieve their commercial objectives is a powerfully motivating force. When we see breakthrough innovations making a difference in the world, it is hugely satisfying and the main reason we love our work.
Successful trade mark oppositions for leading Italian bank
As part of a long-standing relationship with an Italian IP firm, we have advised one of Italy’s largest banking groups, on UK trade mark matters.
Global pharmaceutical company successfully defends patent for use of antidepressant medicine
We were instructed by two global pharmaceutical companies, H. Lundbeck A/S and Takeda Pharmaceuticals, to defend an opposition filed against their patent to an antidepressant medication vortioxetine (marketed as Brintellix).
Full-service IP approach means fast-track robotics SME can focus on growth
With a need to balance scientific invention with commercial objectives, the company needed IP advisers who could both gain the confidence of its scientists and engineers and help it meet its commercial objectives.